小RNA
抑制器
生物
多重耐药
抗药性
非编码RNA
基因
癌症
生物信息学
基因表达
癌症研究
基因表达调控
核糖核酸
计算生物学
遗传学
作者
Ewa Gajda,Małgorzata Grzanka,Marlena Godlewska,Damian Gaweł
出处
期刊:Pharmaceuticals
[Multidisciplinary Digital Publishing Institute]
日期:2021-02-12
卷期号:14 (2): 149-149
被引量:23
摘要
MicroRNAs (miRNAs, miRs) are small non-coding RNA (ncRNA) molecules capable of regulating post-transcriptional gene expression. Imbalances in the miRNA network have been associated with the development of many pathological conditions and diseases, including cancer. Recently, miRNAs have also been linked to the phenomenon of multidrug resistance (MDR). MiR-7 is one of the extensively studied miRNAs and its role in cancer progression and MDR modulation has been highlighted. MiR-7 is engaged in multiple cellular pathways and acts as a tumor suppressor in the majority of human neoplasia. Its depletion limits the effectiveness of anti-cancer therapies, while its restoration sensitizes cells to the administered drugs. Therefore, miR-7 might be considered as a potential adjuvant agent, which can increase the efficiency of standard chemotherapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI